Manifest Technologies is transforming CNS health through AI-powered precision neuroscience and computational neuroimaging. Manifest was founded in 2021 by a group of leading scientists who have created the NAIO™ (Neuroscience and Artificial Intelligence Optimized) platform. NAIO™ incorporates proprietary software and several patents under an exclusive license from Yale University. Manifest is building a suite of specific applications out of the NAIO™ platform to meet the needs of both pharmaceutical CNS R&D and health care providers.
| Date | Amount | Type | Investors | Valuation |
|---|---|---|---|---|
| 03/28/24 | undisclosed | Seed |
ATMA Capital Connecticut Innovations Kaleida Capital | undisclosed |
